Physician profile
Oleg Orlov
NPI 1770141368
$3,475.05
in general payments reported to CMS, 2019-2025
9 companies · $2,242 in 2025
The $2,242 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $253 · 2024: $981 · 2025: $2,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767 · Travel and Lodging: $1,093 · Education: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,767.26 |
| Travel and Lodging | $1,092.62 |
| Education | $615.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,566.24 | 2024-2025 | Turbohawk, Eea, Valiant Captivia |
| Silk Road Medical, INC. | $233.67 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $233.12 | 2025 | General - Vascular Intervention, Enroute Transcarotid Stent |
| Davol INC. | $152.05 | 2024 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $117.65 | 2024 | Keytruda |
| Shockwave Medical, INC | $67.43 | 2025 | |
| Terumo Medical Corporation | $49.14 | 2025 | Glidesheath Slender, Azur Cx Detachable |
| Penumbra, INC. | $36.75 | 2025 | Indigo System |
| Haemonetics Corporation | $19.00 | 2023 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oleg Orlov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.